OTC induction and Arg2 upregulation in AD would attempt to reduce brain ammonia, including reduction of NO and inducible NOS levels, actions that may emphasize the intricate neuroprotective role of the urea cycle pathway [121]. The gene discussed is OTC; the disease is Alzheimer disease.